The casein kinase 1 (CK1) family, a major intracellular serine/threonine kinase, is implicated in multiple pathways; however, understanding its regulation has proven challenging. A recent study published in Science identifying allosteric activation of CK1 by the DEAD-box RNA helicase DDX3 expands our understanding of the control of this abundant kinase family.
primes β-catenin for further phosphorylation by GSK3 and subsequent degradation. How does CK1 accomplish so many different jobs in the Wnt pathway and how is it controlled?
A key mechanism for regulation is CK1s' differential interaction with scaffolds and membranes. CK1δ and CK1ε bind to substrates including Disheveled, Period and NFAT1; CK1α interacts with Axin, and CK1γ localizes to membranes where it phosphorylates LRP6. These interactions take place at protein motifs distinct from the phosphorylation sites. However, binding and co-localization alone are probably not sufficient for precise biological control.
Each CK1 isoform is likely to be regulated differently. CK1α is the smallest member of the family (~38 kDa), and has been thought to be constitutively active. CK1δ and CK1ε have closelyrelated C-terminal domains (148-184 aa) that are actively autophosphorylated, resulting in a kinase-phosphotail interaction that restricts access of protein substrates to the active site of the kinase. CK1δ and CK1ε can be relieved of this auto-inhibition by the action of protein phosphatases that in turn can be stimulated by extracellular signals such as glutaminergic and Wnt signaling [1, 6] . The regulation of CK1γ is not well understood.
Although the kinase domains between CK1s are highly conserved, subtle differences govern their binding to scaffolds. For example, two key residues determine the differential binding of CK1α and CK1ε to Disheveled and Period [8] . Motifs on the scaffolds also facilitate binding to CK1. CK1ε binds to an F-X-X-X-F motif on PER2 and NFAT1 that is quite distal from the phosphorylation sites [9] . The F-X-X-X-F motif is also present on additional CK1 partners including DDX3, although its importance has not yet been tested. The presence of kinase-binding motifs can greatly enhance the phosphorylation of the substrate. Thus, regulating the affinity of CK1 for scaffold-binding sites can have profound effects on rates of phosphorylation.
Protein kinase activity can be controlled by diverse mechanisms, the most commonly studied being phosphorylation, addition or removal of regulatory subunits, and targeting to scaffolds (Figure 1 ). An additional, under-explored mechanism is allosteric regulation. While allostery has a proud history in enzymology, there are only a few examples (e.g., AMP-kinase, phosphorylase kinase) of small-molecule allosteric regulation of protein kinases [reviewed in 10]. Notably, a recent screen for inhibitors of the Wnt/β-catenin pathway identified the drug pyrvinium pamoate as an allosteric activator of CK1α [11] . As a clue to mechanism, pyrvinium bound to but did not activate other CK1 isoforms. However, it could activate CK1δ lacking its C-terminal regulatory domain. This suggests that there is a conserved site in the CK1 family to which pyrvinium binds that allosterically activates the kinases. Additional inhibitory mechanisms, such as the C-terminal phosphodomains of CK1δ and CK1ε, may be able to override the small-molecule activation. The finding of allosteric activation by pyrvinium suggests that endogenous allosteric regulators of the CK1 family may also exist. The DDX genes encode a family of DEAD-box RNA helicases, so named for the "DEAD" (Asp-Glu-Ala-Asp) amino acid sequence in their motif II. The 37 members of the DDX family of proteins have the defining function of unwinding double-stranded RNA in an ATP-dependent manner. DDX proteins are multifunctional, playing roles in translation initiation, mRNA transport and splicesosome assembly [12] . Stimulating CK1 activity is a 'moonlighting' function of DDX3, as key helicase domains and the helicase activity of DDX3 are not required to stimulate Wnt signaling and activate CK1ε.
Unwinding the Wnt action of casein kinase 1
DDX3 and pyrvinium are similar in that both are allosteric activators of CK1. Whether the underlying mechanisms of activation are similar remains to be determined. The C-terminal regulatory domain of CK1δ blocks pyrvinium action [11] , whereas DDX3 is able to activate full-length CK1δ. Pyrvinium and DDX3 might interact with the same region on CK1, but the protein activators may function more efficiently than small molecules. Future structural studies may provide us with more definitive answers.
While DDX3 was identified as a Wnt/β-catenin activator via CK1ε, it also activates CK1α and CK1γ, raising the question of why one activity predominates over the other in the cell-and animal-based assays used by Cruciat et 
